EIN 06-1389829

Sabin Vaccine Institute

IRS 501(c) type
Num. employees
Year formed
Most recent tax filings
Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization made up of scientists, researchers, and advocates dedicated to reducing needless human suffering from vaccine preventable and neglected tropical diseases.
Also known as...
Albert B Sabin Vaccine Institute
Total revenues
Total expenses
Total assets
Num. employees

Program areas at Sabin Vaccine Institute

Vaccine Research & DevelopmentThe Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health. Sabin's Research & Development strategy is to prioritize strong vaccine candidates that lack commercial value, targeting diseases that impact the world's most vulnerable populations. Sabin leverages the expertise of partners in the academic, public, and private sectors, and promotes open-source research.Ebola has taken the lives of nearly 14,000 people during the last decade. To protect communities across the globe from the critical threat posed by Ebola and the closely related, but lesser known, Marburg virus, Sabin is currently developing vaccines for Sudan ebolavirus and Marburg virus diseases based on technology licensed from GSK. The prophylactic vaccine candidates are based on GSK's proprietary ChAd3 platform. In 2019, the U.S. Health and Human Services' Biomedical Advanced Research and Development Authority awarded Sabin a multi-year development contract to advance development of the Marburg and Sudan ebolavirus vaccines
Global ImmunizationDespite scientific advances and international support, 1.5 million people still die each year from diseases that could have been prevented by immunization. Sabin's Global Immunization arm focuses on improving vaccine distribution, increasing uptake, and driving more equitable access to vaccination services. Sabin works on these goals with a multi-layered programmatic approach including: advancing research to understand the social and behavioral drivers for vaccine acceptance and demand; fostering peer to peer collaboration on immunization and building capacity and leadership skills for immunization professionals; coalescing multi-sectoral partners and community leaders and influencers to support the introduction and expansion of new and under-utilized vaccines such as the HPV vaccine; and generating essential epidemiological data to inform immunization policy and implementation decisions for diseases such as typhoid.

Grants made by Sabin Vaccine Institute

GranteeGrant descriptionAmount
Stanford University / The Board of Trustees of the Leland Stanford Junior UniversityEpidemiology Study Site$343,715
Partners Healthcare System / Massachusetts General HospitalEpidemiology Study Site$145,963
Johns Hopkins University (JHU)Vaccine Acceptance Research Site$142,297
...and 6 more grants made

Who funds Sabin Vaccine Institute

Grants from foundations and other nonprofits
National Philanthropic TrustPublic, Societal Benefit$2,385,998
Program for Appropriate Technology in Health Path (PATH)Essential Medicines$2,211,718
Bill & Melinda Gates FoundationEnteric and Diarrheal Diseases$1,353,068
...and 11 more grants received

Personnel at Sabin Vaccine Institute

Amy FinanChief Executive Officer$230,556
Brian DavisChief Financial and Operating Officer$226,967
Davis BrianChief Financial Officer / Chief Financial and Operating Officer / Officer - Chief Operating Officer$166,891
Deleon KijuChief Financial Officer$214,044
Williams MichelleVice President , Operations and Human Resources$241,435
...and 44 more key personnel

Financials for Sabin Vaccine Institute

RevenuesFYE 12/2022
Total grants, contributions, etc.$33,467,236
Program services$0
Investment income and dividends$64,893
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$13,274
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$33,545,403

Form 990s for Sabin Vaccine Institute

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-07990View PDF
2021-122022-11-04990View PDF
2020-122021-07-27990View PDF
2019-122020-09-23990View PDF
2018-122019-10-25990View PDF
...and 9 more Form 990s
Data update history
January 18, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 10, 2024
Updated personnel
Identified 3 new personnel
December 28, 2023
Received grants
Identified 14 new grant, including a grant for $2,211,718 from Program for Appropriate Technology in Health Path (PATH)
December 27, 2023
Used new vendors
Identified 1 new vendor, including
November 25, 2023
Posted financials
Added Form 990 for fiscal year 2021
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Conducts researchLobbyingOperates internationallyNational levelReceives government fundingTax deductible donations
General information
2175 K St NW 400
Washington, DC 20037
Metro area
Washington-Arlington-Alexandria, DC-VA-MD-WV
Website URL
(202) 842-5025
Facebook page
Twitter profile
IRS details
Fiscal year end
Taxreturn type
Form 990
Year formed
Eligible to receive tax-deductible contributions (Pub 78)
NTEE code, primary
H00: Medical Research: General
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Free account sign-up

Want updates when Sabin Vaccine Institute has new information, or want to find more organizations like Sabin Vaccine Institute?

Create free Cause IQ account